Navigation Links
Renaissance in new drugs for rare diseases
Date:5/15/2013

Once famously described as "orphan diseases, too small to be noticed, too small to be funded" in the Hollywood drama "Lorenzo's Oil," rare diseases are getting unprecedented attention today among drug manufacturers, who are ramping up research efforts and marketing new medicines that promise fuller lives for children and other patients with these heartbreaking conditions.

That's the finding of a major examination, published in the current edition of Chemical & Engineering News. C&EN is the weekly newsmagazine of the American Chemical Society, the world's largest scientific society, and reaches more than 138,000 scientists, policymakers, educators and others. Written by Senior Editor Lisa Jarvis after months of interviews with patients, parents, pharmaceutical industry officials and others, the story focuses on the status of new drugs for rare diseases. Those 7,000 conditions affect 200,000 patients or fewer.

Jarvis describes how a combination of factors coalesced to foster a renaissance in drug development for rare diseases. Smaller drug companies, for instance, have shown that it is possible to make big profits from sales of medicines for rare diseases, and larger companies have taken notice. Patient advocacy groups are another driving force. They are directly funding some research and drawing attention and dollars for research. Deeper insights into the genetics of rare diseases and federal legislation extending patent protection for treatments also have helped.


'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert

Page: 1

Related biology news :

1. Renaissance in new drugs for rare diseases: Report in worlds largest scientific socity magazine
2. Newly released FDA draft guidelines for biosimilar drugs to be discussed at conference
3. Nanopills release drugs directly from the inside of cells
4. Genetic variation in East Asians found to explain resistance to cancer drugs
5. Discovery provides blueprint for new drugs that can inhibit hepatitis C virus
6. Internet and new drugs: A challenge for public health
7. Study raises questions about use of anti-epilepsy drugs in newborns
8. Drugs from lizard saliva reduces the cravings for food
9. A new method detects traces of veterinary drugs in baby food
10. La Jolla Institute discovery could lead to new way to screen drugs for adverse reactions
11. MIT-designed cooler preserves tuberculosis drugs, records doses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/16/2016)... June 16, 2016 The ... expected to reach USD 1.83 billion by 2024, ... Research, Inc. Technological proliferation and increasing demand in ... expected to drive the market growth. ... The development of advanced multimodal techniques for ...
(Date:6/9/2016)... , June 9, 2016  Perkotek an innovation leader in attendance control systems ... seamlessly log work hours, for employers to make sure the right employees are actually ... http://photos.prnewswire.com/prnh/20160609/377486LOGO ... ... ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. ... a business relationship that includes integrating Syngrafii,s patented ... branch project. This collaboration will result in greater ... the credit union, while maintaining existing document workflow ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... 23, 2016 A person commits a crime, and ... to track the criminal down. An outbreak of ... Drug Administration (FDA) uses DNA evidence to track down the ... Sound far-fetched? It,s not. The FDA has increasingly used a ... of foodborne illnesses. Put as simply as possible, whole genome ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge ... envision new ways to harness living systems and biotechnology, ... Art (MoMA) in New York City ... 130 participating students, showcased projects at MoMA,s Celeste Bartos ... Paola Antonelli , MoMA,s senior curator of architecture and ...
Breaking Biology Technology: